期刊文献+

5-羟色胺2A受体拮抗剂与糖尿病关系的研究进展 被引量:2

下载PDF
导出
作者 苏颖 刘晓民
出处 《中国煤炭工业医学杂志》 2003年第12期1132-1133,共2页 Chinese Journal of Coal Industry Medicine
  • 相关文献

参考文献11

  • 1[1]Lorenzi M. Glucose toxicity in the vascular complications of dia betes: the cellular perspective[J]. Diabetes Metab Rev, 1992, 8 (2) :85-103
  • 2[2]Nabel EG. Biology of the impaired endothelium[J]. Am J Cardi ol, 1997, 68(12) :6C
  • 3[3]James GM, Hodgson WC. A role for protein kinase C in the at tenuated response to 5 - hydroxytryptamine in aortas from strep tozotocin- diabetic rats[J ]. Eur J Pharmacol, 1997, 322 (1) :55- 58
  • 4[4]Goppelt Struebe M, Wiedemann T, Heusinger Ribeiro J, et al. Cox2 and osteopontin in cocultured platelets and mesangial cells: role of glucocorticoids[ J ]. Kidney Int, 2000, 57 (7) :2229
  • 5[5]Young BA, Johnson RJ, Alpers CE, et al. Cellular events in the evolution of experimental diabetic nephropathy[J]. Kidney Int, 1995, 47(3) :935
  • 6[6]Kasho M, Sakai M, Sasahara T, et al. Serotonin enhances the pro duction of type IV collagen by human mesangial cells[ J ]. Kidney Int, 1998, 54(4): 1083-1092
  • 7[7]Takahashi T, Yano M, Minami J, et al. Sarpogrelate hydrochlo ride, a serotonin 2A receptor antagonist, reduces albuminuria in diabetic patients with early- stage diabetic nephropathy[ J ]. Dia betes Res Clin Pract, 2002, 58(2): 123-129
  • 8[8]Cameron NE, Cotter MA. The effects of 5 - hydroxytryptamine 5 - HT(2) receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats[J ]. Naunyn Schmiedebergs Arch Pharmacol, 2003, 367(6) :607-614
  • 9[9]Vannoutte PM. 5- hydroxytryptamine and vascular disease[J]. Federation Proc, 1983, 42(4) :233
  • 10[10]Van Nueten JM. Lnteration between 5 - hydroxytrptamine and other vasoconserictor substances in the isolated, famoral artery of the rabbit effect of ketanserin (R41 468) [J]. Eur J Pharmacol, 1982, 77(5) :281-282

同被引文献18

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部